Glenmark launches acne drug Winlevi in Europe

Glenmark launches acne drug Winlevi in Europe — Glenmark Pharmaceuticals has launched Winlevi® (clascoterone) 10 mg/g cream in key European markets for acne vulgaris. The product launch expands its dermatology portfolio in Europe. Winlevi is a first-in-class topical androgen receptor inhibitor. This move strengthens Glenmark’s presence in the European skincare market.

📊 STOCKS: GLENMARK | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #DrugLaunch